ZFP36L1 and neoplasm: It can not only accelerate tumor development by activating the JAK-STAT pathway, but also promote the abnormal activation of PD-L1 through binding with ZFP36L1, leading to T cell exhaustion and accelerating the progression of tumor developmen (Qiu et al., 2023; Wei X. et al., 2024).